Advertisement
Journal Home
Search for

125 Periodical Search Results

You searched for "tamoxifen" within Cancer Treatment Reviews

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 125 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7

display abstract citation download email a colleague
Display:

  1. Management of primary and advanced breast cancer in older unfit patients (medical treatment) , 17 September 2009
    M. Aapro, Silvio Monfardini, Antonio Jirillo, Umberto Basso
    Cancer Treatment Reviews
    October 2009 (Vol. 35, Issue 6, Pages 503-508)
    Abstract | Full Text | Full-Text PDF (167 KB)

  1. Commentary: Evidence profiles for breast cancer: Benefit/Harms data based on the totality of randomized evidence , 03 November 2006
    Lodovico Balducci
    Cancer Treatment Reviews
    February 2007 (Vol. 33, Issue 1, Pages 85-86)
    Full Text | Full-Text PDF (108 KB)

  1. Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10
    Hetty Carraway, Antonio C. Wolff
    Cancer Treatment Reviews
    May 2004 (Vol. 30, Issue 3, Pages 303-307)
    Full Text | Full-Text PDF (151 KB)

  1. Hormonal therapy for male breast cancer: A different approach for a different disease , 14 February 2006
    Zeina A. Nahleh
    Cancer Treatment Reviews
    April 2006 (Vol. 32, Issue 2, Pages 101-105)
    Abstract | Full Text | Full-Text PDF (90 KB)

  1. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma
    Pierce K. Chow
    Cancer Treatment Reviews
    October 2005 (Vol. 31, Issue 6, Pages 491-495)
    Full Text | Full-Text PDF (92 KB)

  1. Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.
    Christina Davies
    Cancer Treatment Reviews
    October 2004 (Vol. 30, Issue 6, Pages 583-588)
    Full Text | Full-Text PDF (248 KB)

  1. Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies , 20 May 2008
    Robert E. Coleman, Jean-Jacques Body, Julie R. Gralow, Allan Lipton
    Cancer Treatment Reviews
    2008 (Vol. 34Supplement 1, Pages S31-S42)
    Abstract | Full Text | Full-Text PDF (346 KB)

  1. Combining systemic therapies with radiation in breast cancer , 25 May 2009
    Krzysztof Adamowicz, Małgorzata Marczewska, Jacek Jassem
    Cancer Treatment Reviews
    August 2009 (Vol. 35, Issue 5, Pages 409-416)
    Abstract | Full Text | Full-Text PDF (194 KB)

  1. Beyond tamoxifen: Extended and late extended endocrine therapy in postmenopausal early breast cancer , 14 November 2007
    David Dodwell, Debbie Williamson
    Cancer Treatment Reviews
    April 2008 (Vol. 34, Issue 2, Pages 137-144)
    Abstract | Full Text | Full-Text PDF (165 KB)

  1. Breast cancer prevention: present and future
    A.K. Salih, I.S. Fentiman
    Cancer Treatment Reviews
    October 2001 (Vol. 27, Issue 5, Pages 261-273)
    Abstract | Abstract + References | Full-Text PDF (239 KB)

  1. Clinical development of fulvestrant (‘Faslodex’) , 04 October 2005
    Anthony Howell, Paul Abram
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S3-S9)
    Abstract | Full Text | Full-Text PDF (133 KB)

  1. Bone health in postmenopausal women with early breast cancer: How protective is tamoxifen? , 18 June 2007
    Hongliu Ding, Terry S. Field
    Cancer Treatment Reviews
    October 2007 (Vol. 33, Issue 6, Pages 506-513)
    Abstract | Full Text | Full-Text PDF (197 KB)

  1. Neoadjuvant endocrine therapy in breast cancer , 29 November 2006
    M.J. Beresford, D. Ravichandran, A. Makris
    Cancer Treatment Reviews
    February 2007 (Vol. 33, Issue 1, Pages 48-57)
    Abstract | Full Text | Full-Text PDF (191 KB)

  1. Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme , 04 October 2005
    Guenther G. Steger, Maya Gips, Sergio D. Simon, Ana Lluch, Jefferson Vinholes, Bella Kaufman, Andrew Wardley, Louis Mauriac
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S10-S16)
    Abstract | Full Text | Full-Text PDF (109 KB)

  1. The effects of tamoxifen on the female genital tract
    Elżbieta Senkus-Konefka, Tomasz Konefka, Jacek Jassem
    Cancer Treatment Reviews
    May 2004 (Vol. 30, Issue 3, Pages 291-301)
    Abstract | Full Text | Full-Text PDF (215 KB)

  1. Moving into the future: Treatment of bone metastases and beyond , 24 October 2005
    Gabriel N. Hortobagyi
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 3, Pages 9-18)
    Abstract | Full Text | Full-Text PDF (298 KB)

  1. Tamoxifen: Important considerations of a multi-functional compound with organ-specific properties , 22 December 2006
    Maneesh N. Singh, Helen F. Stringfellow, Evangelos Paraskevaidis, Pierre L. Martin-Hirsch, Francis L. Martin
    Cancer Treatment Reviews
    April 2007 (Vol. 33, Issue 2, Pages 91-100)
    Abstract | Full Text | Full-Text PDF (1113 KB)

  1. The management of women at high risk for the development of breast cancer: risk estimation and preventative strategies
    George H Sakorafas
    Cancer Treatment Reviews
    April 2003 (Vol. 29, Issue 2, Pages 79-89)
    Abstract | Full Text | Full-Text PDF (139 KB)

  1. Gynaecological aspects of tamoxifen treatment in breast cancer patients
    R. Obwegeser, L. Auerbach, E. Kubista
    Cancer Treatment Reviews
    September 1997 (Vol. 23, Issue 5, Pages 289-304)
    Abstract + References | Full-Text PDF (2244 KB)

  1. A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer , 23 May 2005
    David Dodwell, Ignace Vergote
    Cancer Treatment Reviews
    June 2005 (Vol. 31, Issue 4, Pages 274-282)
    Abstract | Full Text | Full-Text PDF (317 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 125 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement